General Information


DRAVP ID  DRAVPe00189

Peptide Name   P29

Sequence  KWLTEWIPLTAEC

Sequence Length  13

UniProt ID  No entry found

Source  Synthetic construct(derived from Pep-A)



Activity Information


Target Organism  HIV

Assay  RT-Polymerase Assay

Activity 

  • [Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =1 ± 0.4 μM).
  • NOTE:Ki: inhibition constants

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • No cytotoxicity information or data found in the reference(s) presented in this entry

Binding Target  Reverse Transcriptase

Mechanism  HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.



Structure Information


PDB ID  None

Predicted Structure Download  DRAVPe00189

Linear/Cyclic  Linear

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C75H112N16O20S

Absent amino acids  DFGHMNQRSVY

Common amino acids  ELTW

Mass  1589.87

Pl  4.53

Basic residues  1

Acidic residues  2

Hydrophobic residues  6

Net charge  -1

Boman Index  -180

Hydrophobicity  5.38

Aliphatic Index  97.69

Half Life 

  •     Mammalian:1.3 hour
  •     Yeast:3 min
  •     E.coli:2 min

Extinction Coefficient cystines  11000

Absorbance 280nm  916.67

Polar residues  3



Literature Information


Literature 1

Title   A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.

Pubmed ID   18952602

Reference   J Biol Chem. 2009 Jan 2;284(1):254-264.

Author   Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.

DOI   10.1074/jbc.M802199200